Why the study?
The known effects of Gastrodin on cerebral ischemia prompted investigation into its potential role in arrhythmia associated with cardiac ischemia-reperfusion injury in rats.
Does Gastrodin reduce cardiac arrhythmia and myocardial injury in a rat model of ischemia-reperfusion?
Does Gastrodin reduce cardiac arrhythmia and myocardial injury in a rat model of ischemia-reperfusion?
Gastrodin demonstrates potential anti-arrhythmic effects in a rat model of myocardial ischemia-reperfusion injury by targeting gap junction proteins.
Answers are grounded in this paper and cite their sources.
Gastrodin attenuated IR-induced arrhythmias in rats; leaves open clinical translation pending prospective human trials.
The effects of Gastrodin (GD) on cerebral ischemia stimulated researchers to investigate its possible role in the progression of arrhythmia associated with cardiac ischemia-reperfusion (IR) damage in rats. 40 Sprague-Dawley rats were divided into four groups: Sham, Model, GD 50 mg/kg, and GD 100 mg/kg. Myocardial ischemia (MI) was caused by the procedure of ligating the left coronary artery, followed by reperfusion. Heart rate (HR), mean arterial pressure (MAP), and rate pressure product (RPP) in rats were assessed before and after ischemia and reperfusion, as well as cardiac arrhythmia in experimental rats. The I/R damage was evaluated by measuring levels of Na +-K+ATPase and Ca2+-Mg2+ATPase, Creatine Kinase-MB (CK-MB), Cardiac Troponin I (cTnI), Gap Junction α-1 (GJα-1), Phospho-GJα-1/total-GJα-1, Kir2.1, Bax, Bcl-2, and oxidative indicators. MGL’s Autodock and Vina programs were used for in silico docking studies to identify possible interactions between GJα-1 and Gastrodin. The animals in the model group expressed a substantial decrease in HR, MAP, and RPP compared to the Sham group. GD-treated rats revealed slightly higher values compared to the model group. Expression of CK-MB and cTnI was reduced, and Na+-K+ATPase and Ca2+-Mg2+ATPase expression was increased on GD pre-conditioning. Phospho-Cx43/total-Cx43 ratio and Bax expression were increased, whereas GD reduced Bcl-2 expression. In silico molecular docking studies suggested the potential binding of GD with the GJα-1 protein, thus confirming the in vivo results. GD corrected the arrhythmia in rats subjected to I/R injury by increasing Na+-K+ATPase and Ca2+-Mg2+ATPase expression, targeting GJα-1, and modulating the expression of Kir2.1.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: